[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aclarion Inc (ACON)

Aclarion Inc (ACON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,116
  • Shares Outstanding, K 2,462
  • Annual Sales, $ 80 K
  • Annual Income, $ -7,230 K
  • EBIT $ -9 M
  • EBITDA $ -8 M
  • 60-Month Beta 1.22
  • Price/Sales 92.33
  • Price/Cash Flow N/A
  • Price/Book 0.36

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-1.05
  • Number of Estimates 1
  • High Estimate $-1.05
  • Low Estimate $-1.05
  • Prior Year $-2.75
  • Growth Rate Est. (year over year) +61.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.62 +9.92%
on 06/25/26
3.61 -20.27%
on 06/04/26
-0.40 (-12.20%)
since 05/29/26
3-Month
2.62 +9.92%
on 06/25/26
3.94 -26.90%
on 04/09/26
-0.20 (-6.49%)
since 03/30/26
52-Week
2.34 +23.07%
on 02/05/26
12.03 -76.06%
on 10/13/25
-4.64 (-61.73%)
since 06/30/25

Most Recent Stories

More News
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

BROOMFIELD, Colo., June 10, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc .,  (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),  a commercial-stage healthcare technology company leveraging biomarkers...

ACONW : 0.0215 (-22.94%)
ACON : 2.88 (-0.35%)
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform

Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion’s AI-driven platform for chronic low back pain. Program aims to follow successful reimbursement wins in the...

ACONW : 0.0215 (-22.94%)
ACON : 2.88 (-0.35%)
Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

BROOMFIELD, Colo., June 08, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. , (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW) , a commercial-stage healthcare technology company that is leveraging...

ACONW : 0.0215 (-22.94%)
ACON : 2.88 (-0.35%)
Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

BROOMFIELD, Colo., June 08, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc ., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW) , a commercial-stage healthcare technology company that is leveraging...

ACONW : 0.0215 (-22.94%)
ACON : 2.88 (-0.35%)
Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation

Expands availability of Nociscan in the greater Los Angeles area with leading neuroscience group Adds to growing body of real-world evidence with study comparing chemical biomarker data from Nociscan...

ACONW : 0.0215 (-22.94%)
ACON : 2.88 (-0.35%)
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study

Award-winning, NIH funded study indicates that immune-associated biological signatures may play a role in some cases of back pain Nociscan’s underlying MRS technology enabled measurement of intradiscal...

ACONW : 0.0215 (-22.94%)
ACON : 2.88 (-0.35%)
Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal

BROOMFIELD, Colo., May 28, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc ., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and...

ACONW : 0.0215 (-22.94%)
ACON : 2.88 (-0.35%)
Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment

“Matching the right procedure to the right patient is what moves the field forward” Lanman Spinal Neurosurgery is a leading spine-focused private practice recognized for its expertise in complex...

ACONW : 0.0215 (-22.94%)
ACON : 2.88 (-0.35%)
Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.

BROOMFIELD, Colo., May 06, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. , (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging...

ACONW : 0.0215 (-22.94%)
ACON : 2.88 (-0.35%)
Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine

BROOMFIELD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc.,  (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),  a commercial-stage healthcare technology company that is leveraging...

ACONW : 0.0215 (-22.94%)
ACON : 2.88 (-0.35%)

Business Summary

Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed...

See More

Key Turning Points

3rd Resistance Point 3.02
2nd Resistance Point 2.97
1st Resistance Point 2.93
Last Price 2.88
1st Support Level 2.84
2nd Support Level 2.79
3rd Support Level 2.75

See More

52-Week High 12.03
Fibonacci 61.8% 8.33
Fibonacci 50% 7.19
Fibonacci 38.2% 6.04
Last Price 2.88
52-Week Low 2.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.